Larimar Therapeutics, Inc. (LRMR)

NASDAQ: LRMR · Real-Time Price · USD

4.620

-0.230 (-4.74%)

At close: Mar 27, 2026, 4:00 PM EDT

4.610

-0.010 (-0.22%)

After-hours: Mar 27, 2026, 5:29 PM EDT

Larimar Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-165.67	-80.6	-36.95	-35.36	-50.64
Depreciation & Amortization	0.35	0.32	0.31	0.32	0.33
Stock-Based Compensation	7	8.8	7.62	6.62	5.47
Other Adjustments	-1.7	-5.26	-1.84	-0.77	-0.02
Changes in Accounts Payable	2.79	1.14	-0.4	0.03	-0.97
Changes in Accrued Expenses	37.55	13.44	-1.02	1.82	0.75
Changes in Other Operating Activities	6.47	-8.59	-1.17	-0.22	2.97
Operating Cash Flow	-113.2	-70.76	-33.46	-27.57	-42.11
Capital Expenditures	-0.09	-0.52	-0.16	-0.1	-0.33
Purchases of Investments	-83.6	-227.87	-101.23	-133.61	-8.25
Proceeds from Sale of Investments	184	143	134.75	42.75	32.75
Investing Cash Flow	100.31	-85.39	33.35	-90.96	24.17
Issuance of Common Stock	65.09	161.88	0.03	75.26	19.89
Net Common Stock Issued (Repurchased)	65.09	161.88	0.03	75.26	19.89
Financing Cash Flow	65.09	161.88	0.03	75.26	19.89
Net Cash Flow	52.19	5.74	-0.08	-43.27	1.95
Free Cash Flow	-113.29	-71.28	-33.62	-27.67	-42.44
Free Cash Flow Per Share	-1.55	-1.16	-0.77	-1.07	-2.47
Levered Free Cash Flow	-118.6	-74.82	-39.4	-33.51	-47.9
Unlevered Free Cash Flow	-125.42	-85.1	-44.2	-34.69	-47.73

Updated Mar 19, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q